Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
6.88
+0.37 (5.68%)
At close: Oct 29, 2024, 4:00 PM
6.90
+0.02 (0.29%)
After-hours: Oct 29, 2024, 7:51 PM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $580.92 million as of October 29, 2024. Its market cap has increased by 79.46% in one year.
Market Cap
580.92M
Enterprise Value
355.87M
1-Year Change
79.46%
Ranking
Category
Stock Price
$6.88
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $406.10M to $580.92M, an increase of 43.05%. That is a compound annual growth rate of 10.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 458.10M | 14.24% |
| Dec 29, 2023 | 401.00M | 4.73% |
| Dec 30, 2022 | 382.90M | 114.39% |
| Dec 31, 2021 | 178.60M | -56.02% |
| Feb 5, 2021 | 406.10M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Axogen | 583.37M |
| Celcuity | 578.04M |
| ORIC Pharmaceuticals | 574.92M |
| Savara | 572.81M |
| Tectonic Therapeutic | 570.81M |
| Aura Biosciences | 541.70M |
| Third Harmonic Bio | 540.43M |
| Surmodics | 536.30M |